Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27228253 | 1.00 | LCK (0.32) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL27908468 | 1.00 | LCK (0.32) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL28070612 | 1.00 | LCK (0.32) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL15329517 | 1.00 | LCK (0.32) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL8010264 | 1.00 | LCK (0.32) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL3666628 | 0.97 | — | — | |
| SCHEMBL29055256 | 0.93 | LCK (0.42) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL647281 | 0.89 | — | — | |
| SCHEMBL19439531 | 0.89 | LCK (0.37) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL8554463 | 0.82 | DNM1 (0.40) | LCKPPARDZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957900-B | Magnetic porous polyion liquid material, preparation method and device thereof | 国家纳米科学中心 | 2024-07-05 | — | — | CN | disclosed |
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | EMORY UNIVERSITY (US) | 2023-02-23 | — | — | US | disclosed |
| CN-114957900-A | Magnetic porous polyion liquid material, preparation method and device thereof | 国家纳米科学中心 | 2022-08-30 | — | — | CN | disclosed |
| CN-113166115-A | Monomeric and multimeric anti-HBV agents | 埃默里大学 | 2021-07-23 | — | — | CN | disclosed |
| CN-107285335-A | A kind of preparation method of the preparation method of template and load Ti MFI molecular sieves | 广东工业大学 | 2017-10-24 | — | — | CN | disclosed |
| CN-104402020-A | Micro-mesoporous beta molecular sieve and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2015-03-11 | — | — | CN | disclosed |
| US-20140142178-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | KAREUS THERAPEUTICS, SA (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20140121267-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | KAREUS THERAPEUTICS, SA (CH) | 2014-05-01 | — | — | US | disclosed |
| US-8623897-B2 | Methods and compositions for treatment of diabetes and dyslipidemia | KAREUS THERAPEUTICS, SA (CH) | 2014-01-07 | — | — | US | disclosed |
| CN-103327974-A | Methods and compositions for treating diabetes and dyslipidemia | KAREUS THERAPEUTICS SA | 2013-09-25 | — | — | CN | disclosed |
| US-7468441-B2 | 1-imidazolymethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing | HUNSTMAN ADVANCED MATERIALS AMERICAS INC. (US) | 2008-12-23 | — | — | US | disclosed |
| US-20060211845-A1 | 1-Imidazolymethyl -substituted -2-naphtols and their use as accelerators for low - temperature curing | HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) | 2006-09-21 | — | — | US | disclosed |
| EP-1613604-B1 | 1-IMIDAZOLYLMETHYL-SUBSTITUTED-2-NAPHTOLS AND THEIR USE AS ACCELERATORS FOR LOW-TEMPERATURE CURING | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2006-07-05 | — | — | EP | disclosed |
| EP-1613604-A1 | 1-IMIDAZOLYLMETHYL-SUBSTITUTED-2-NAPHTOLS AND THEIR USE AS ACCELERATORS FOR LOW-TEMPERATURE CURING | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004092141-A1 | 1-IMIDAZOLYMETHYL-SUBSTITUTED-2-NAPHTOLS AND THEIR USE AS ACCELERATORS FOR LOW-TEMPERATURE CURING | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2004-10-28 | — | — | WO | disclosed |
| CN-1105558-C | 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same and use for treating insulin resistance | ROCHE DIAGNOSTICS GMBH (DE) | 2003-04-16 | — | — | CN | disclosed |
| US-5968982-A | TREATMENT OF DIABETES | ROCHE DIAGNOSTICS GMBH (DE) | 1999-10-19 | — | — | US | disclosed |
| US-5871670-A | Electroconductive composition | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-02-16 | — | — | US | disclosed |
| CN-1171050-A | 2, 2-Dichloroalkanecarboxylic acids, method for the production thereof, medicaments containing the same and use thereof for the treatment of insulin resistance | BOEHRINGER MANNHEIM GMBH (DE) | 1998-01-21 | — | — | CN | disclosed |
| EP-0377175-A2 | Pattern forming composition and process for forming pattern using the same | HITACHI, LTD. (JP) | 1990-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211845-A1 | 1-Imidazolymethyl -substituted -2-naphtols and their use as accelerators for low - temperature curing | NOP2, LMNA, RPL39 | LCK 4824/4885PPARD 4695/4885ZDHHC20 4673/4885 |
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | HAVCR2, HMBS, HDGF | LCK 4017/4885PPARD 1519/4885ZDHHC20 4148/4885 |
| US-20140121267-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | GPR119, FFAR1, INSR | LCK 1823/4885PPARD 273/4885ZDHHC20 1066/4885 |
| US-20140142178-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA | DHCR7, INSR, GPR119 | LCK 1152/4885PPARD 324/4885ZDHHC20 1178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.